Difficulty: Medium
Average Score: 83%
Practice
Which of the following drugs works on LPL and EL with a decrease in TG, LDL, and HDL without affecting LDL-R?
Correct answer
C
Rationale
C' is correct because evinacumab targets ANGPTL3, enhancing lipoprotein lipase (LPL) and endothelial lipase (EL), lowering TG, LDL, and HDL without LDL receptor (LDL-R) involvement, per pharmacology. 'A' upregulates LDL-R. 'B' inhibits cholesterol synthesis. 'D' mainly lowers TG via LPL. Evinacumab's unique profile fits.